SG11202005749WA - Pentosan polysulfate and medicine containing pentosan polysulfate - Google Patents
Pentosan polysulfate and medicine containing pentosan polysulfateInfo
- Publication number
- SG11202005749WA SG11202005749WA SG11202005749WA SG11202005749WA SG11202005749WA SG 11202005749W A SG11202005749W A SG 11202005749WA SG 11202005749W A SG11202005749W A SG 11202005749WA SG 11202005749W A SG11202005749W A SG 11202005749WA SG 11202005749W A SG11202005749W A SG 11202005749WA
- Authority
- SG
- Singapore
- Prior art keywords
- pentosan polysulfate
- medicine containing
- polysulfate
- pentosan
- medicine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0057—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Xylans, i.e. xylosaccharide, e.g. arabinoxylan, arabinofuronan, pentosans; (beta-1,3)(beta-1,4)-D-Xylans, e.g. rhodymenans; Hemicellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Heart & Thoracic Surgery (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Compounds Of Unknown Constitution (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017244051 | 2017-12-20 | ||
PCT/JP2018/046537 WO2019124363A1 (ja) | 2017-12-20 | 2018-12-18 | ポリ硫酸ペントサン及びポリ硫酸ペントサンを含む医薬 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202005749WA true SG11202005749WA (en) | 2020-07-29 |
Family
ID=66993402
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202005749WA SG11202005749WA (en) | 2017-12-20 | 2018-12-18 | Pentosan polysulfate and medicine containing pentosan polysulfate |
Country Status (16)
Country | Link |
---|---|
US (1) | US11344570B2 (zh) |
EP (1) | EP3730521B1 (zh) |
JP (1) | JP6662503B2 (zh) |
KR (1) | KR102533822B1 (zh) |
CN (1) | CN111511773B (zh) |
AU (1) | AU2018387999B2 (zh) |
CA (1) | CA3086301A1 (zh) |
ES (1) | ES2946281T3 (zh) |
FI (1) | FI3730521T3 (zh) |
HU (1) | HUE062342T2 (zh) |
MX (1) | MX2020006605A (zh) |
PH (1) | PH12020550775A1 (zh) |
PL (1) | PL3730521T3 (zh) |
PT (1) | PT3730521T (zh) |
SG (1) | SG11202005749WA (zh) |
WO (1) | WO2019124363A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112020004787A2 (pt) * | 2017-09-12 | 2020-09-24 | Oji Holdings Corporation | polissulfato de pentosano, composição farmacêutica, anticoagulante, e, método para produzir polissulfato de pentosano |
TWI727770B (zh) | 2019-04-26 | 2021-05-11 | 泰宗生物科技股份有限公司 | 用於預防反覆性泌尿道感染的藥物組合物 |
WO2022114111A1 (ja) * | 2020-11-27 | 2022-06-02 | マルホ株式会社 | 医薬品又は化粧品用組成物 |
Family Cites Families (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4843100B1 (zh) | 1969-09-05 | 1973-12-17 | ||
US4168742A (en) | 1978-03-27 | 1979-09-25 | Hudson Products Corporation | Tube bundle |
FR2538404B1 (zh) | 1982-12-28 | 1985-08-23 | Anic Spa | |
FR2543145B1 (fr) * | 1983-03-24 | 1986-10-17 | Sanofi Sa | Nouveaux sulfates de xylanes, leur procede de preparation et leur activite anti-thrombotique et hypolipemiante |
JPS60112708A (ja) | 1983-11-24 | 1985-06-19 | Maruho Kk | 皮膚用保湿剤 |
FR2572731B1 (fr) * | 1984-11-07 | 1987-03-06 | Sanofi Sa | Nouveaux sulfates de xylanes de bas poids moleculaires, leur procede de preparation et leur activite antithrombotique et hypolipemiante par voie orale |
JPS61130302A (ja) | 1984-11-30 | 1986-06-18 | Tokyo Univ | 抗凝血活性を有する硫酸化リボフラナン及びその製造法 |
JPS61130301A (ja) | 1984-11-30 | 1986-06-18 | Tokyo Univ | 抗凝血活性を有する硫酸化キシロフラナン及びその製造法 |
US5672334A (en) | 1991-01-16 | 1997-09-30 | Access Pharmaceuticals, Inc. | Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans |
FR2645745B1 (fr) | 1989-04-12 | 1991-09-27 | Anben Ste Civile | Compositions therapeutiques pour le traitement ou la prevention du ronflement |
DE3917982A1 (de) | 1989-06-02 | 1990-12-06 | Behringwerke Ag | Verwendung von xylanpolyhydrogensulfaten zur therapie von zellproliferations-bedingten erkrankungen |
FR2648463B1 (fr) | 1989-06-14 | 1993-01-22 | Inst Fs Rech Expl Mer | Polysaccharides sulfates, agent anticoagulant et agent anticomplementaire obtenus a partir de fucanes d'algues brunes et leur procede d'obtention |
AU647484B2 (en) | 1990-04-26 | 1994-03-24 | Cytrx Corporation | Composition and method for topical treatment of damaged or diseased tissue |
US20010005720A1 (en) | 1995-06-07 | 2001-06-28 | U.S.A. As Represented By The Secretary Department Of Health And Human Services | Method of treating chronic progressive vascular scarring diseases |
DE19632840A1 (de) | 1996-08-14 | 1998-02-19 | Landsberger Albert | Vitamin A-haltige Zusammensetzung |
JPH10195107A (ja) | 1997-01-10 | 1998-07-28 | Shiseido Co Ltd | オリゴ硫酸化ヒアルロン酸 |
JP4336905B2 (ja) | 1997-12-19 | 2009-09-30 | マルホ株式会社 | 硫酸化多糖類含有皮膚保湿乳剤性ローション剤 |
US6593310B1 (en) | 2000-11-21 | 2003-07-15 | Arthropharm Pty. Ltd. | Treatment of osteoporosis |
DE10141106A1 (de) | 2001-08-22 | 2003-03-13 | Aventis Pharma Gmbh | Verwendung von Heparinoid-Derivaten zur Behandlung und Diagnose von mit Heparinoiden behandelbaren Erkrankungen |
JP4073661B2 (ja) | 2001-12-20 | 2008-04-09 | 王子製紙株式会社 | 酸性キシロオリゴ糖組成物の製造方法 |
JP3772749B2 (ja) | 2002-01-25 | 2006-05-10 | 王子製紙株式会社 | メラニン生成抑制剤 |
JP2003221339A (ja) | 2002-01-29 | 2003-08-05 | Oji Paper Co Ltd | 抗炎症剤 |
ITMI20031618A1 (it) | 2003-08-06 | 2005-02-07 | Inalco Spa | Derivati polisaccaridici dotati di alta attivita' |
PT1748781E (pt) | 2004-05-27 | 2013-01-22 | Baxter Int | Processos para o tratamento de distúrbios de hemorragias utilizando polissacarídeos sulfatados |
AU2005271349B2 (en) | 2004-08-05 | 2011-10-27 | Ivax Drug Research Institute Ltd | Polysulfated glycosides and salts thereof |
US20060194759A1 (en) | 2005-02-25 | 2006-08-31 | Eidelson Stewart G | Topical compositions and methods for treating pain and inflammation |
CA2616230A1 (en) | 2005-07-22 | 2007-02-01 | Trf Pharma, Inc. | Method for treating sickle cell disease and sickle cell disease sequelae |
NZ571537A (en) | 2006-04-03 | 2012-06-29 | Nutramax Lab Inc | Stabilized pentosan polysulfate (PPS) formulations and methods of analayzing them |
GB0610350D0 (en) | 2006-05-25 | 2006-07-05 | Univ Liverpool | prevention and/or treatment of neuodegenerative disorders |
JPWO2008066193A1 (ja) | 2006-11-27 | 2010-03-11 | チッソ株式会社 | 化粧料組成物 |
US20100105889A1 (en) | 2007-03-06 | 2010-04-29 | Pandurang Balwant Deshpande | Process for the preparation of pentosan polysulfate or salts thereof |
FI121811B (fi) * | 2007-06-01 | 2011-04-29 | Upm Kymmene Corp | Uudet dispersiot ja menetelmä niiden valmistamiseksi |
HUP0900072A2 (hu) | 2009-02-06 | 2010-09-28 | Egis Gyogyszergyar Nyilvanosan | Transzdermális gyógyszerkészítmények |
WO2009087581A1 (en) | 2008-01-04 | 2009-07-16 | Alembic Limited | An improved process for the preparation of pentosan polysulfate or salts thereof |
JP2009196915A (ja) | 2008-02-20 | 2009-09-03 | Ezaki Glico Co Ltd | 化粧品用組成物 |
AU2008100725B4 (en) * | 2008-07-04 | 2008-10-02 | Parnell Technologies Pty Ltd | A sulfated polysaccharide compound for clinical use |
FR2935386B1 (fr) | 2008-08-26 | 2010-09-10 | Sanofi Aventis | Nouveaux polysaccharides a activite antithrombotique comprenant une liaion covalente avec une chaine amine |
CN102300870B (zh) | 2009-02-02 | 2014-12-03 | 大塚化学株式会社 | 低分子量多硫酸化透明质酸衍生物和含有它的医药 |
CN102061323B (zh) | 2010-11-10 | 2013-09-25 | 山东龙力生物科技股份有限公司 | 一种植物木质纤维素的综合利用工艺 |
WO2012101544A1 (en) | 2011-01-29 | 2012-08-02 | Alembic Pharmaceuticals Limited | An improved process for the preparation of pentosan polysulfate or salts thereof |
WO2012114349A1 (en) | 2011-02-23 | 2012-08-30 | Cadila Healthcare Limited | An improved process for the preparation of pentosan polysulfate sodium |
CN102766225B (zh) | 2011-05-06 | 2015-08-05 | 上海医药工业研究院 | 一种戊聚糖聚硫酸钠的制备方法以及一种寡聚木糖 |
WO2013186857A1 (ja) | 2012-06-12 | 2013-12-19 | 株式会社リボミック | Fgf2に対するアプタマー及びその使用 |
ITMI20130112A1 (it) | 2013-01-24 | 2014-07-25 | Chemi Spa | Metodo di qualificazione di preparazioni di pentosan polifosfato, sue materie prime e processi di produzione |
JO3529B1 (ar) | 2013-02-08 | 2020-07-05 | Amgen Res Munich Gmbh | مضاد التصاق خلايا الدم البيض من أجل التخفيف من الاثار السلبية الممكنة الناتجة عن مجالات ارتباط cd3- المحدد |
JP6132302B2 (ja) * | 2013-05-28 | 2017-05-24 | リーディアント・バイオサイエンシーズ・ソシエタ・アノニマLeadiant Biosciences S.A. | 抗血管新生活性を有し、抗凝血効果を有さない、ヘパラナーゼ阻害剤としての部分的に脱硫酸化されたグリコサミノグリカンの誘導体 |
CN103320548A (zh) | 2013-06-24 | 2013-09-25 | 稼禾生物股份有限公司 | 一种利用农作物秸秆制备低聚木糖和纤维素的方法 |
JP6403317B2 (ja) * | 2013-07-19 | 2018-10-10 | 学校法人慶應義塾 | 抗腫瘍剤 |
SI3298047T1 (sl) * | 2015-05-20 | 2022-04-29 | Chemi Spa | Postopek za pripravo polisaharidov |
US20180318336A1 (en) | 2015-05-27 | 2018-11-08 | Vanguard Therapeutics, Inc. | Pentosan polysulfate sodium for the treatment of sickle cell disease |
CN106832020A (zh) | 2015-12-04 | 2017-06-13 | 长春工业大学 | 一种玉米秸秆戊聚糖硫酸酯的制备工艺 |
CN105907896B (zh) | 2016-05-16 | 2019-11-12 | 中国科学院广州能源研究所 | 一种利用木质纤维原料联产高浓度木糖和低聚木糖的方法 |
SG11202001824RA (en) | 2016-08-31 | 2020-04-29 | Oji Holdings Corp | Production method for acidic xylooligosaccharide, and acidic xylooligosaccharide |
JP6225321B1 (ja) * | 2016-08-31 | 2017-11-08 | 王子ホールディングス株式会社 | ポリ硫酸ペントサンの製造方法 |
JP6281659B1 (ja) | 2017-02-28 | 2018-02-21 | 王子ホールディングス株式会社 | ポリ硫酸ペントサン、医薬組成物及び抗凝固剤 |
BR112019025030A2 (pt) * | 2017-05-31 | 2020-06-16 | Oji Holdings Corporation | Preparação umidificante tópica. |
BR112020004787A2 (pt) * | 2017-09-12 | 2020-09-24 | Oji Holdings Corporation | polissulfato de pentosano, composição farmacêutica, anticoagulante, e, método para produzir polissulfato de pentosano |
-
2018
- 2018-12-18 CN CN201880081841.6A patent/CN111511773B/zh active Active
- 2018-12-18 MX MX2020006605A patent/MX2020006605A/es unknown
- 2018-12-18 AU AU2018387999A patent/AU2018387999B2/en active Active
- 2018-12-18 JP JP2019561110A patent/JP6662503B2/ja active Active
- 2018-12-18 HU HUE18890627A patent/HUE062342T2/hu unknown
- 2018-12-18 WO PCT/JP2018/046537 patent/WO2019124363A1/ja unknown
- 2018-12-18 EP EP18890627.5A patent/EP3730521B1/en active Active
- 2018-12-18 CA CA3086301A patent/CA3086301A1/en active Pending
- 2018-12-18 US US16/955,641 patent/US11344570B2/en active Active
- 2018-12-18 SG SG11202005749WA patent/SG11202005749WA/en unknown
- 2018-12-18 FI FIEP18890627.5T patent/FI3730521T3/fi active
- 2018-12-18 KR KR1020207017451A patent/KR102533822B1/ko active IP Right Grant
- 2018-12-18 PT PT188906275T patent/PT3730521T/pt unknown
- 2018-12-18 ES ES18890627T patent/ES2946281T3/es active Active
- 2018-12-18 PL PL18890627.5T patent/PL3730521T3/pl unknown
-
2020
- 2020-06-01 PH PH12020550775A patent/PH12020550775A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
MX2020006605A (es) | 2020-09-10 |
PL3730521T3 (pl) | 2023-10-09 |
AU2018387999B2 (en) | 2021-06-17 |
HUE062342T2 (hu) | 2023-10-28 |
JPWO2019124363A1 (ja) | 2020-04-02 |
EP3730521B1 (en) | 2023-05-17 |
WO2019124363A1 (ja) | 2019-06-27 |
EP3730521A1 (en) | 2020-10-28 |
US11344570B2 (en) | 2022-05-31 |
CA3086301A1 (en) | 2019-06-27 |
KR20200099533A (ko) | 2020-08-24 |
JP6662503B2 (ja) | 2020-03-11 |
KR102533822B1 (ko) | 2023-05-17 |
CN111511773A (zh) | 2020-08-07 |
PH12020550775A1 (en) | 2021-04-26 |
BR112020010887A2 (pt) | 2020-11-10 |
ES2946281T3 (es) | 2023-07-14 |
FI3730521T3 (fi) | 2023-07-25 |
PT3730521T (pt) | 2023-06-19 |
US20200384012A1 (en) | 2020-12-10 |
CN111511773B (zh) | 2023-01-13 |
AU2018387999A1 (en) | 2020-06-18 |
EP3730521A4 (en) | 2021-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201801747B (en) | Medication packaging and dose regimen system | |
ZA201705591B (en) | Medication packaging and dose regimen system | |
HUE064782T2 (hu) | Tartály orvosi és/vagy gyógyszerészeti termékekhez | |
SG11201608401VA (en) | Thermoplastic elastomer composition, stopper for medical container, and medical container | |
HK1258671A1 (zh) | 藥物包裝和分配系統 | |
HUE059074T2 (hu) | Tartálytartó eszköz és orvosi tartálykészlet | |
HK1252026A1 (zh) | 藥物組合及其應用 | |
HUE060518T2 (hu) | Pentozán poliszulfát, gyógyászati készítmény és antikoaguláns | |
SG11202002528SA (en) | Radioactive drug | |
IL271434A (en) | Devices and methods for overfilling drug containers | |
EP3182953A4 (en) | Medication packaging and dose regimen system | |
SG11202005749WA (en) | Pentosan polysulfate and medicine containing pentosan polysulfate | |
EP3183187A4 (en) | Medication packaging and dose regimen system | |
IL250729B (en) | A pyrazolothiazole compound and a drug containing it | |
IL250418A0 (en) | Use of pill / tablet / capsule minocycline acyclogonosine, atorvastatin and vitamin D in the treatment of rheumatoid arthritis | |
GB201406172D0 (en) | Therapy and pharmaceutical composition | |
SG11202002250VA (en) | Pentosan polysulfate and method for producing pentosan polysulfate | |
IL250419A0 (en) | Use of a pill/tablet/capsule of minocycline, plataconazole and atorvastatin in the treatment of multiple sclerosis | |
GB201519644D0 (en) | Therapy and pharmaceutical composition | |
DK3193968T3 (da) | Emballage til medicinsk anordning og medikament | |
EP3622941C0 (en) | PACKAGED MEDICINE | |
GB201715316D0 (en) | Medicine Etc | |
GB201718647D0 (en) | Medical container | |
RS20170652A1 (sr) | Berza lekova i medicinskih sredstava | |
GB201701116D0 (en) | Medical devices and their manufacture |